Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.8fepf Regulatory News (SANB)

Share Price Information for Sant Uk.8fepf (SANB)

Share Price is delayed by 15 minutes
Get Live Data
142.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (3.597%)
Market Cap: -
SANB Live PriceLast checked at - London Stock Exchange

Intraday Sant Uk.8fepf Share Chart

Directorate Change

13 Dec 2024 10:00

RNS Number : 0381Q
Santander UK Group Holdings PLC
13 December 2024
Β 

13 December 2024

Β 

Β 

Santander UK plc and Santander UK Group Holdings plc - Board Appointment of Executive Director

Santander UK today announces the appointment of Enrique Alvarez Labiano, Chief Executive Officer of Retail and Business Banking, as an Executive Director to the Boards of Santander UK plc and Santander UK Group Holdings plc. His appointment to the Board of Santander UK plc is subject to regulatory approval and both appointments will take immediate effect on receipt of that approval.

Enrique began his Santander career in 2015 as Group Head of Strategy and Head of the Group Chairman's office. He moved to the UK in 2019 as Head of Strategy and Corporate Development, before he took up the role of Chief People Officer in 2020 and was subsequently appointed Head of Everyday Banking in 2021. He's been CEO of Retail and Business Banking since 2023.

Santander UK Chair, William Vereker said: "I am delighted to welcome Enrique to the Boards of Santander UK. He brings us over 20 years of international business experience from a range of blue-chip companies and the wider Santander Group and I look forward to working with him."

- Ends -

Santander UK is a financial services provider in the UK that offers a wide range of personal and commercial financial products and services. At 30 June 2024, the bank had around 19,600 employees and serves around 14 million active customers, including 7 million digital customers via a nationwide 444 branch network, telephone, mobile and online banking. Santander UK is subject to the full supervision of the FCA and the PRA in the UK. Santander UK plc customers' eligible deposits are protected by the FSCS in the UK.

Banco Santander (SAN SM, STD US, BNC.LN) is a leading commercial bank, founded in 1857 and headquartered in Spain and one of the largest banks in the world by market capitalization. The group's activities are consolidated into five global businesses: Retail & Commercial Banking, Digital Consumer Bank, Corporate & Investment Banking (CIB), Wealth Management & Insurance and Payments (PagoNxt and Cards). This operating model allows the bank to better leverage its unique combination of global scale and local leadership. Banco Santander aims to be the best open financial services platform providing services to individuals, SMEs, corporates, financial institutions and governments. The bank's purpose is to help people and businesses prosper in a simple, personal and fair way. Banco Santander is building a more responsible bank and has made a number of commitments to support this objective, including raising €220 billion in green financing between 2019 and 2030. In the first quarter of 2024, Banco Santander had €1.3 trillion in total funds, 166 million customers, 8,400 branches and 211,000 employees.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAGPGGPPUPCUBW
12
Date   Source Headline
7th Mar 20254:12 pmRNSPublication of Suppl.Prospcts
7th Mar 202510:30 amRNSAnnual Financial Report
17th Feb 202512:47 pmRNSNotice of Early Redemption Series 1244
17th Feb 202512:45 pmRNSNotice of Early Redemption Series 1217 and 1218
5th Feb 202510:39 amRNSPublication of Suppl.Prospcts
5th Feb 202510:32 amRNSPublication of Suppl.Prospcts
5th Feb 20257:10 amRNSQuarterly Management Statement – Q4 2024
28th Jan 20254:32 pmRNSDirectorate Change
23rd Jan 20253:00 pmRNSPublication of Final Terms
7th Jan 202511:35 amRNSSeries 1241-Early Redemption
13th Dec 202410:00 amRNSDirectorate Change
9th Dec 20244:33 pmRNSPublication of Final Terms
26th Nov 20244:07 pmRNSPublication of Listing Prospectus
20th Nov 20241:13 pmRNSPublication of Suppl.Prospcts
20th Nov 20241:08 pmRNSPublication of Suppl.Prospcts
20th Nov 20247:15 amRNS3rd Quarter Results
18th Nov 20244:06 pmRNSSeries 1237 and 1238 Early Redemption
15th Nov 20244:26 pmRNSThird Quarter 2024 Results Announcement
28th Oct 20246:31 pmRNSThird Quarter 2024 Results Announcement
21st Oct 202410:00 amRNSDirectorate Change
16th Sep 20243:58 pmRNSIssue 1233 and 1234 Early Redemption Notice
9th Sep 20244:24 pmRNSPublication of Final Terms
9th Aug 20242:30 pmRNSPublication of Suppl.Prospcts
9th Aug 20242:29 pmRNSPublication of Suppl.Prospcts
9th Aug 20247:15 amRNSHalf-year Report
24th Jul 202412:28 pmRNSPublication of Suppl.Prospcts
24th Jul 202412:27 pmRNSPublication of Suppl.Prospcts
24th Jul 20247:15 amRNSQuarterly Management Statement Q2 2024
22nd Jul 20243:34 pmRNSCirc re. Early Redemption Series 1229 and 1230
18th Jun 20241:24 pmRNSPublication of Supplementary Prospectus
13th Jun 20243:00 pmRNSBoard Change
31st May 202411:28 amRNSIssue 1202 and 1203 Notice of Early Redemption
24th May 20243:09 pmRNSIssue 1225 and 1226 Notice of Early Redemption
20th May 202412:27 pmRNSPublication of Final Terms
30th Apr 20247:15 amRNSQuarterly Management Statement - Q1 2024
8th Apr 20247:00 amRNSPublication of a Prospectus
3rd Apr 20241:21 pmRNSIssue 1221 and 1222 Early Redemption Notice
18th Mar 20244:51 pmRNSPublication of Final Terms
6th Mar 20248:48 amRNSPublication of a Prospectus
1st Mar 202412:11 pmRNSPublication of Supplementary Prospectus
1st Mar 20247:00 amRNSAnnual Financial Report - 31 December 2023
23rd Feb 20243:36 pmRNSPublication of Final Terms
31st Jan 202412:54 pmRNSPublication of Suppl.Prospcts
31st Jan 202412:49 pmRNSPublication of Suppl.Prospcts
31st Jan 20247:15 amRNSQuarterly Management Statement – Q4 2023
29th Jan 20207:15 amRNSQ4 19 - Quarterly Management Statement
29th Oct 20157:30 amRNS3rd Quarter Results
30th Jul 20157:45 amRNSQuarterly Management Statement - 30 June 2015
30th Sep 20088:57 amRNSStabilisation Notice
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.